Impact of the Addition of Daratumumab to the Standard Bortezomib-Thalidomide-Dexamethasone Regimen on Hematopoietic Stem Cell Mobilization and Collection, Post-Transplant Engraftment and Infectious Complications: A Case-Control Multicentre Real-Life Analy

• Gianluca Cavallaro

Affiliations

Gianluca Cavallaro

a:1:{s:5:"en_US";s:77:"Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo";}